| Dr Kevin Buchanan, MD | |
|
11 Main St, Randolph, VT 05060-1330 | |
| (802) 728-4466 | |
| (802) 728-4197 |
| Full Name | Dr Kevin Buchanan |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 32 Years |
| Location | 11 Main St, Randolph, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194807040 | NPI | - | NPPES |
| 38694 | Other | VT | BLUE CROSS |
| 0108291Y0VT01 | Other | VT | ANTHEM NH |
| 2002983 | Other | VT | CIGNA |
| 0VN1795 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 042-0009705 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gifford Medical Center | Randolph, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clara Martin Center | 1951395367 | 12 |
News Archive
Covalon Technologies Ltd., an advanced medical technologies company, today announced the following financial results for its year ended September 30, 2010
In a new survey of physicians who treat breast cancer patients, only one-third said they had good access to trained medical interpreters or telephone language-interpretation systems when they needed it. Poor access to interpreters can compromise physician-patient communication that is critically important in cancer care.
A team of researchers led by scientists at St. Jude Children's Research Hospital is looking at ways to improve how blood-forming stem cells can be used for therapeutic interventions. The work has uncovered a group of genes that regulate how hematopoietic stem cells start to grow and thrive in mice. The function of many of these genes was previously unknown. Reconstitution of a robust blood-forming system is essential for recovery from many catastrophic diseases as well as from chemotherapy treatments.
A patchwork of state laws creates a labyrinth that can make it confusing to navigate incapacitated patients' medical wishes.
Acesis, the enterprise software firm, headquartered in Silicon Valley and focused on healthcare, today announced its expanded technology solution, the Acesis Performance Improvement Platform that provides hospitals digital performance assessment capabilities that can be easily set up for each hospital's unique vision of quality care.
› Verified 8 days ago
| Entity Name | Clara Martin Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386710861 PECOS PAC ID: 1951395367 Enrollment ID: O20060315000608 |
News Archive
Covalon Technologies Ltd., an advanced medical technologies company, today announced the following financial results for its year ended September 30, 2010
In a new survey of physicians who treat breast cancer patients, only one-third said they had good access to trained medical interpreters or telephone language-interpretation systems when they needed it. Poor access to interpreters can compromise physician-patient communication that is critically important in cancer care.
A team of researchers led by scientists at St. Jude Children's Research Hospital is looking at ways to improve how blood-forming stem cells can be used for therapeutic interventions. The work has uncovered a group of genes that regulate how hematopoietic stem cells start to grow and thrive in mice. The function of many of these genes was previously unknown. Reconstitution of a robust blood-forming system is essential for recovery from many catastrophic diseases as well as from chemotherapy treatments.
A patchwork of state laws creates a labyrinth that can make it confusing to navigate incapacitated patients' medical wishes.
Acesis, the enterprise software firm, headquartered in Silicon Valley and focused on healthcare, today announced its expanded technology solution, the Acesis Performance Improvement Platform that provides hospitals digital performance assessment capabilities that can be easily set up for each hospital's unique vision of quality care.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Buchanan, MD 751 Quail John Rd, East Thetford, VT 05043-9615 Ph: (802) 785-4417 | Dr Kevin Buchanan, MD 11 Main St, Randolph, VT 05060-1330 Ph: (802) 728-4466 |
News Archive
Covalon Technologies Ltd., an advanced medical technologies company, today announced the following financial results for its year ended September 30, 2010
In a new survey of physicians who treat breast cancer patients, only one-third said they had good access to trained medical interpreters or telephone language-interpretation systems when they needed it. Poor access to interpreters can compromise physician-patient communication that is critically important in cancer care.
A team of researchers led by scientists at St. Jude Children's Research Hospital is looking at ways to improve how blood-forming stem cells can be used for therapeutic interventions. The work has uncovered a group of genes that regulate how hematopoietic stem cells start to grow and thrive in mice. The function of many of these genes was previously unknown. Reconstitution of a robust blood-forming system is essential for recovery from many catastrophic diseases as well as from chemotherapy treatments.
A patchwork of state laws creates a labyrinth that can make it confusing to navigate incapacitated patients' medical wishes.
Acesis, the enterprise software firm, headquartered in Silicon Valley and focused on healthcare, today announced its expanded technology solution, the Acesis Performance Improvement Platform that provides hospitals digital performance assessment capabilities that can be easily set up for each hospital's unique vision of quality care.
› Verified 8 days ago